Safety and efficacy of Wharton's jelly‐derived mesenchymal stem cells with teriparatide for osteoporotic vertebral fractures: A phase I/IIa study

Safety and efficacy of Wharton's jelly‐derived mesenchymal stem cells with teriparatide for osteoporotic vertebral fractures: A phase I/IIa study

Abstract Osteoporotic vertebral compression fractures (OVCFs) are serious health problems. We conducted a randomized, open‐label, phase I/IIa study to determine the feasibility, safety, and effectiveness of Wharton's jelly‐derived mesenchymal stem cells (WJ‐MSCs) and teriparatide (parathyroid h...

Full description

Bibliographic Details
Main Authors: JeongHyun Shim, Kyoung‐Tae Kim, Kwang Gi Kim, Un‐Yong Choi, Jae Won Kyung, Seil Sohn, Sang Heon Lim, Hyemin Choi, Tae‐Keun Ahn, Hye Jeong Choi, Dong‐Eun Shin, Inbo Han
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:Stem Cells Translational Medicine
Subjects:
mesenchymal stem cells
osteoporosis
teriparatide
vertebral compression fracture
Wharton's jelly
Online Access:https://doi.org/10.1002/sctm.20-0308

Internet

https://doi.org/10.1002/sctm.20-0308

Similar Items